Creo Medical Group PLC develops and commercializes advanced energy medical devices for minimally invasive endoscopic procedures, primarily targeting cancer and pre-cancer indications in the gastrointestinal tract, pancreas, liver, and lung. The company operates through its proprietary CROMA energy platform, offering products such as Speedboat Notch and SpydrBlade Flex, which enhance treatment efficacy and patient outcomes. Creo serves healthcare providers globally, focusing on improving surgical techniques and reducing procedure times and costs. The company collaborates with other sectors, including robotic surgery, to expand its market reach and product applications.